Drawing for VIVAGEL

USPTO serial 79197477

VIVAGEL

Reviewed by CopyMark Law Group

Reg. 5477567Status 709
Filing date
Status date
Registration date
May 29, 2018
Examiner
ALLEN, BIANCA LEIGH
Law office
TMO LAW OFFICE 123

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with VIVAGEL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceuticals, pharmaceutical preparations, and pharmaceutical drugs for medical purposes for prevention of viral and bacterial disease, namely, bacterial vaginosis, herpes simplex virus, human papilloma virus, and human immunodeficiency virus (HIV); chemical preparations for pharmaceutical and medical purposes for the prevention of bacterial vaginosis, herpes simplex virus, human papilloma virus and human immunodeficiency virus (HIV); chemical compounds in the nature of antimicrobial or ph balancing or microbial balancing substances all for medical purposes, namely, for treating and preventing vaginal microbial imbalance, vaginal pH imbalance, vaginal odor and discharge, bacterial vaginosis, viral STD, vaginaitis, vaginal thrush, vaginal disease symptom relief including itching, odor, and discharge, for maintaining a healthy balance of vaginal flora and for the reestablishment of the bacterial vaginal flora; polyvalent compounds and dendrimers sold as integral component parts of pharmaceuticals preparations all for medical purposes for the treatment and prevention of bacterial vaginosis, herpes simplex virus, human papilloma virus, human immunodeficiency virus (HIV); antimicrobial preparations, namely, microbicidal preparations in the nature of gels, films, solutions, lubricants for vaginal and rectal use for prevention of bacterial vaginosis, herpes simplex virus, human papilloma virus, human immunodeficiency virus (HIV); chemical contraceptives, namely, sponges, gels, foams, creams, films, solutions, suspensions and lotions for use in preventing HIV and other sexually transmitted infections; prophylactic preparations for prevention of pregnancy and microbial disease of the reproductive system, namely, chemical contraceptives and antibacterial preparations in the nature of sponges, suppositories, sexual lubricants, gels, foams, creams, films, solutions, suspensions and lotions; pharmaceutical preparations in the nature of vaginal gels and lubricants all for the prevention of pregnancy and sexually transmitted infections and diseases of the human reproductive systemSECTION 71 - CANCELLED—
010Contraceptive apparatus, namely, intravaginal cervical barriers; prophylactic instruments for use to prevent pregnancy and disease, namely, condoms, diaphragms, and intrauterine devicesSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 9, 2026RNWLINTERNATIONAL REGISTRATION RENEWED—
Mar 19, 2026Further Decision Processed by IB—
Feb 4, 2026XXSSGENERIC MADRID TRANSACTION SENT TO IB—
Feb 4, 2026INNAINVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE—
Feb 4, 2026XXCRGENERIC MADRID TRANSACTION CREATED—
Aug 13, 2025INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Dec 13, 2024C71TCANCELLED SECTION 71—
May 29, 2023REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Jun 7, 2019ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Apr 26, 2019NREPNEW REPRESENTATIVE AT IB RECEIVED—
Dec 8, 2018COC.CORRECTION UNDER SECTION 7 - PROCESSED—
Dec 4, 2018CORRCORRECTION FROM IB ENTERED - NO REVIEW REQUIRED—
Nov 28, 2018APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Oct 30, 2018TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Oct 30, 2018ES7RTEAS SECTION 7 REQUEST RECEIVED—
Oct 6, 2018FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Sep 13, 2018FICSFINAL DISPOSITION NOTICE SENT TO IB—
Sep 13, 2018FIMPFINAL DISPOSITION PROCESSED—
Aug 29, 2018FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
May 29, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 16, 2018GPNXNOTIFICATION PROCESSED BY IB—
Mar 13, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 21, 2018OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Feb 21, 2018OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Feb 21, 2018NPUBNOTICE OF PUBLICATION—
Feb 6, 2018EXPTEXPARTE APPEAL TERMINATED—
Feb 6, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 6, 2018CNEAEXAMINERS AMENDMENT MAILED—
Feb 6, 2018XAECEXAMINER'S AMENDMENT ENTERED—
Feb 6, 2018CNEAEXAMINERS AMENDMENT -WRITTEN—
Jan 23, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 23, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 22, 2018EXPIEX PARTE APPEAL-INSTITUTED—
Jan 22, 2018JURTJURISDICTION RESTORED TO EXAMINING ATTORNEY—
Jan 22, 2018EXAFEXPARTE APPEAL RECEIVED AT TTAB—
Jan 21, 2018ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Jul 27, 2017NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jul 21, 2017CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jul 20, 2017CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jul 7, 2017INNPPARTIAL INVALIDATION PROCESSED BY THE IB—
Jun 27, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 27, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 23, 2017ALIEASSIGNED TO LIE—
Jun 9, 2017RFNTREFUSAL PROCESSED BY IB—
May 25, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 18, 2017NREPNEW REPRESENTATIVE AT IB RECEIVED—
Apr 28, 2017CRCVCORRECTION TRANSACTION RECEIVED FROM IB—
Feb 10, 2017NREPNEW REPRESENTATIVE AT IB RECEIVED—
Feb 9, 2017RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Feb 9, 2017RFRRREFUSAL PROCESSED BY MPU—
Feb 9, 2017RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Feb 8, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 6, 2017DOCKASSIGNED TO EXAMINER—
Dec 20, 2016MAFRAPPLICATION FILING RECEIPT MAILED—
Dec 16, 2016NREPNEW REPRESENTATIVE AT IB RECEIVED—
Dec 15, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 12, 2016LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Dec 1, 2016SDRCSN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB—

Frequently asked questions

Related guidance